Sascha Alilovic
Managing Partner
After having spent about 20 years in transactional roles (M&A, IPOs and other capital market transactions), having experience in founding corporate finance boutiques and as well as having had managerial roles in global corporates, Sascha joined SHS in 2018. Having a computer science degree next to his finance background, he is thrilled by the opportunities of digitalization in the healthcare sector. Amongst other things, Sascha is focusing on the end of the lifecycle of SHS’s investments – the partnering of SHS’s portfolio companies with strategic acquirers. Sascha serves on several medtech and life science company boards and led SHS’s first investment outside of the German speaking regions. Sascha is also promoting the necessity and opportunities of promoting innovative medtech, being a frequent speaker at European life science investment conferences.
When it comes to soccer, Sascha is a big supporter of Germany’s best football team – at least in his perception there is no one who beats Borussia Dortmund with that. Neither his colleagues at SHS nor his neighbors in Munich would agree. When it comes to European championships, he is a bit more open minded – being a son of Croatians who moved to Germany and having a Russian wife with a Swedish passport allows him to favor quite some teams in tournaments. He is also trying to beat the odds by running every morning prior to coming to the office, no matter what time of the year it is.
Guillaume Balz
Investment Manager
Guillaume joined the SHS team in January 2023. After obtaining his bachelor's degree in economics in Dortmund and Athens, he completed his master's degree in finance and strategic management in Copenhagen. He then decided to join Simon-Kucher & Partners where he advised companies on marketing, sales, pricing and go-to-market. From the beginning of his career, he was passionate about and specialised in the medtech and digital health sector. After three years in strategy consulting, he moved to SHS.
In addition to SHS, however, the call of the mountains drew him back to southern Germany, as racing biking and skiing are his undisputed hobbies. Another of his passions is culinary arts. He likes to spoil himself and others with new delicacies and tried-and-tested classics - for example, his homemade tiramisu is out of this world.
Cornelia Gänsicke
Head of Controlling and authorized signatory
Cornelia knows that the devil is in the detail. Since joining SHS in 2007, she has been working to improve the controlling of SHS’s portfolio companies and is in charge of reporting to the investors of SHS’s funds. On top she takes care of the funds’ financial and regulatory issues. Prior to SHS she used to work in similar roles in global conglomerates.
In her private time, Cornelia enjoys trips to the countryside. Another favorite pastime is skiing together with her family.
Heike Grammer
Controlling
Heike has been enchanting her colleagues since 2018 with her incomparable charm combined with high competence. Active in accounting and controlling, she is also one of the key people behind the further digitalization of all processes at SHS - from contract signatures to personnel and accounting tools, her colleagues are getting dizzy at the speed she sets. She is also the central project manager for SHS' investor days, which could hardly run more smoothly despite all the adversities. She is responsible for all internal personnel processes.
Privately, Heike also likes to let the (male) dolls dance. For years Heike has been training a men's dance group, which has its biggest performances especially during carnival time.
Regine Hujer
Head of Administration and Management Assistant
Regine has been with SHS for nearly 20 years, covering all areas you could possibly imagine in supporting the management partners. She excels in generating clear and concise presentations, managing the sometimes chaotic travel and meeting schedules of the partners, organizing all internal and external events and running the PR at SHS. She also ensures that all colleagues are always equipped with functioning hardware and software. Regine has been the heart and the soul whenever needed, completely unshakeable by the world around her, always keeping her good mood and having a nice word for everyone. As a qualified instructor she is in charge of training new SHS employees doing a vocational education.
Regine’s green conscience extends beyond SHS – she is a convinced vegetarian, rides the bicycle to work and privately every day (“there is no such thing as unsuitable weather!”) and in general walks the talk. During late hours she loves to immerse into suspenseful thrillers which keep her awake even after she has switched the lights off.
Stine Kögler
Analyst
Stine Kögler has been working as an analyst at SHS since 2019. Due to her great perceptiveness, which is essentially based on her studies of biology with a focus on microbiology and genetics, it is easy for her to structure the large number of incoming investment inquiries at SHS and assign them accordingly.
Stine loves spending time with her family, especially during the spring and summer months, actually she is never at home, but explores the countless hiking trails of the Swabian Alb with her loved ones.
Katharina Kolenda
Trainee
Katharina is the youngest member of the SHS family. She has been training as an office administrator at SHS since 2020, whirling through the offices and within a very short time she has become an integral part of the team. Powerpoint presentations, scheduling, evaluations - she implements everything quickly and efficiently.
As a real child of the region, Katharina is certainly known to some people through her performances with her show dance group - the more splendid and colorful the costume, the more likely Katharina is in it!
Hubertus Leonhardt
Managing Partner
Hubertus is a seasoned investment professional with a strong focus on financial and operational performance of investments. Being a Chartered Financial Analyst (CFA) and certified tax consultant he strengthened his business acumen as a corporate finance manager at Arthur Andersen before he joined SHS in 1997. Being instrumental in legal and tax structuring of investments SHS portfolio companies and shareholders benefit greatly from his experience. He is an active board member of several medtech companies, having being involved as lead investor in a number of companies that achieved a successful exit be it by an IPO or by trade sale.
In his private time, Hubertus loves to challenge his younger colleagues with cycle races where he is holding the company record by far. On top he has probably skied every slope in Europe.
Dr. Cornelius Maas
Partner
Cornelius started his tenure at SHS while still being a professional handball player and a student of international management. Being a vivid internal champion at SHS for digital health companies, he also quickly became sought after to drive leads and opportunities over the line – a strong dealmaker in its best meaning. He is an excellent negotiator trying to balance the needs of all parties to get to a joint win/win situation. That made him the natural manager to do the first pure healthtech investment at SHS. Cornelius represents SHS in a number of boards of life science, medtech and digital health companies.
In his spare time Cornelius satisfied his scientific curiosity by researching the space of corporate innovation in healthcare, leading to a PhD. Being a former world champion, he keeps his level of fitness by playing in a local handball team.
Lukas Maucher
CFO
Lukas joined the SHS team in April 2022. With his experience in the business sector gained during his career at one of the Big Four auditing firms in Southern Germany, Lukas brings the best qualifications for his position as CFO of the SHS team. Before joining Ernst & Young as a manager and authorised signatory, Lukas completed his Bachelor of Science in Business Administration with a focus on corporate accounting and finance at the LMU in Munich. He then completed his Master's degree at the University of Mannheim with a focus on Accounting & Taxation. At SHS, his work focuses on controlling, regulatory issues, investor relations, HR and financial issues.
At 2 metres tall, you wouldn't initially expect Lukas to be in football. However, as an active player, former coach and Bayern Munich fan club founder, it quickly becomes clear that football is his greatest passion. But he is also enthusiastic about other sports and politics.
Anna Schleifer
Investment Manager
Anna has been part of the SHS team since September 2022. She completed her Bachelor of Science at the School of Business and Economics at Maastricht University. In addition, she did a Double Degree Master at EDHEC Business School / Maastricht University in Corporate Finance and Banking.
She then joined William Blair International as an analyst, where she had previously completed an internship. She was there for about three years until she was promoted to Associate and joined SHS.
As determined as she is in her job, she also pursues her hobbies. She enjoys endurance sports, especially triathlon, because exercise in the great outdoors is her balance to her professional life. Anna is a convinced vegetarian who likes to go on culinary journeys. From time to time, however, she also seeks peace and quiet at home with a good book or an afternoon with her cat, whom she is always teaching little tricks. After all, he can already do "sit".
Elisaveta Slobodyanik
Trainee
Elisaveta has been part of the SHS team since September 2022. As a trainee, her fields of activity are wide-ranging, from everyday tasks such as mail and email traffic and presentation and document processing to supporting activities in the areas of administration, PR and event planning. With her calm and thoughtful manner, Elisaveta always performs her tasks reliably.
In her free time, Elisaveta enjoys Asian culture. Her enthusiasm for everything Asian, especially Chinese culture and cuisine, even goes so far that she has been learning Mandarin at the adult education centre for some time. Another of her hobbies is dancing. From ballet to breakdancing to jazz, she has tried it all. At SHS, she is also known as a big sweet tooth. Every now and then, she has to listen to teasing, such as: "Don't you like tea with your sugar?"
Uwe Steinbacher
Managing Partner
Uwe has, is and will always be an entrepreneur in his heart. Coming from a family that owned a number of small businesses, he founded his first company when he was 18 and sold his 3rd company before he was 26. After completing his formal training in finance and management, he started to share his experiences by becoming a growth investor in innovative companies, the typical German “Mittelstand” that is the backbone of the economy. Uwe is renowned as the perfect sparring partner to bounce some ideas regarding strategy around as he has seen the “real market” in all its facets himself. Uwe serves on several boards of medtech and life science companies.
Remembering basically all rock songs by heart, Uwe is frequently being asked at company outings to perform as singer and guitarist on demand. Being a strong supporter of Eintracht Frankfurt he does not necessarily agree on Germany’s top football club with his colleagues – but who does?
Sarah Stelzer
PR and Marketing
Born and raised in Tübingen, Sarah is a true native of Tübingen. At SHS, she is responsible for PR and marketing. With her cheerful and charming manner, she takes care of press releases, social media contributions, coordinates projects with our portfolio companies and is also SHS's mouthpiece to the outside world. Her degree in German and art history helps her to always find the right words and to get to the heart of the matter. Various internships in the PR field complement the already perfect prerequisites for her job.
Since her early childhood, Sarah has also been passionate about singing. She had singing, piano and ballet lessons from an early age. During her school and university years, she participated in several bands and choirs. Her passion for singing is only surpassed by her fascination with Korea. Even though Sarah's enthusiasm usually falls on deaf ears among her colleagues, she regularly raves about offbeat K-pop bands and Korean dramas. Sentences like "That's not sushi, that's kimbap" are the order of the day.
Kerstin Stuck
Analyst
Kerstin has been working as an analyst at SHS since September 2021. Due to her combination of studies in biology and business administration, she is predestined to categorise and allocate the investment requests at SHS.
Her spare time is also dedicated to her enthusiasm for biology. In her large vegetable garden, she grows every vegetable that our climate zone has to offer. When she is not working in the garden or looking after the chickens, Kerstin travels all over Europe with her husband and two children in their brightly coloured caravan.
Manfred Ulmer-Weber
Managing Partner
During his studies in Tübingen, Manfred became aware of the opportunities that lie in innovative healthcare companies. He started as an intern with the plan to stay for 10 weeks and has stayed with SHS for more than ten years now. Manfred is known to keep a cool head when everyone around him keeps ranting – soft in his speech, consistent and convincing in his arguments. He represents SHS on a number of medtech and life science companies.
Manfred used to be a semi-pro table tennis player and still has a bet for anyone that no one will be able to return even once on 20 of his serves. He also has a hobby he shares with many –watching soccer. Being a big supporter of VfB Stuttgart, he does not necessarily agree on the best football club in Germany with his colleagues.
David Wehner
Senior Investment Manager
After combining his molecular biotechnology background with a business degree David co-founded a medtech company which raised a seven digit Euro amount in several financing rounds. After that he joined a large corporate in order to build a new life science business unit to then come back again to his entrepreneurial core – helping innovative medtech and life science companies and thereby patients. His analytical skills combined with firsthand experience make him a great sparring partner for entrepreneurs.
David enjoys running, probably even more after having had the first date with his now wife doing exactly that – going for a run together. He has completed several marathons and has the Boston marathon on top of his wish list – probably again with his better half.
Dr. André Zimmermann
Partner
André was always passionate about innovative life science companies. Being a rare combination of being scientifically minded (a PhD in molecular biology is enough proof in the eyes of his colleagues) he is also trained in finance and banking. That led him to become an entrepreneur himself - first in a biomedical startup and, after successfully selling his shares, joining SHS to help other entrepreneurs in the life science space. André is our key person to liaise with partners – be it strategic investors into our funds, be it strategic partners for potential business development activities. On top he is in charge of ESG activities.
Next to enjoying as much time with his family as possible, André has a passion in education. He has led an initiative to have a bilingual education in the public system, from crèche to high school diploma. Hundreds of students have benefitted from it. On top he is well known for his baking capabilities – don’t miss it!
Anika Landgraf
Legal Counsel
As external legal counsel, Anika Landgraf is the first point of contact for the SHS team in legal matters.
She is a lawyer at the Reutlingen-based law firm RWT. Previously, she was an in-house lawyer at a listed company in the healthcare sector.
Friedrich Baldinger
Active for SHS since 2014 and from 2023 in the role of Senior Advisor.
He is a managing partner of teamCon GmbH, a management consulting firm specialising in M&A and corporate finance, as well as a court-certified expert for credit and leasing.
Mr. Baldinger is also intensively involved with young companies and the development of new business models, especially during his time at the Upper Austrian High-Tech Fund and the incubator of the Softwarepark Hagenberg. He has held various positions at Raiffeisenlandesbank Oberösterreich, including board member of activ factoring AG in Munich, as well as credit risk manager. Mr Baldinger began his professional career as a financial manager at an international property development company.
Prof. Dr. Armin Bolz
SHS senior advisor since 2014, managing partner of Corscience GmbH & Co. KG, which he founded in 2001 together with the medical technology group Weinmann in Erlangen.
Mr. Bolz received his doctorate and habilitation at the University of Erlangen on physical issues of implant development. His results led to new types of coating technologies which are still used today in the field of stent and pacemaker production worldwide. From 1995-1999 Mr. Bolz was head of development at Biotronik GmbH & Co. KG. In 1999, he accepted the appointment as Professor of Biomedical Engineering at the Karlsruhe Institute of Technology (KIT). From 1999 to 2001, he was chairman of the German Society for Biomedical Engineering, and in 2001 he was also a member of the VDE board.
With numerous patents, prizes and publications on biophysical and biomedical engineering topics, he is an important source of advice for SHS.
Dr. Markus Enzelberger
SHS Senior Advisor since 2018. Dr. Enzelberger is Entrepreneur in Residence at Versant Ventures in Basel where he is building new companies in the field of drug development and biotechnology.
Previously, he was Chief Scientific Officer of MorphoSys AG, an MDAX and Nasdaq-listed Munich-based biotechnology company engaged in the discovery and development of antibody drugs, where he spent 18 years. He oversaw the development of MorphoSys's core antibody generation technologies (HuCAL and Ylanthia) and has been involved in more than 100 therapeutic antibody programs, including Tremfya (Guselkumab), a psoriasis drug approved by Jansen in 2017.
Dr. Enzelberger completed his post-doctoral stay with Steven Quake at the California Institute of Technology in the field of microfluidic biological assays, where he also co-invented Fluidigm's key technologies. In addition, Dr. Enzelberger studied chemistry and received a PhD in natural sciences from the Technical University of Stuttgart. He wrote his diploma thesis at Bayer and his doctorate at BASF on the use of enzymes in chemical processes.
Ruth Ch. Geßner
SHS Senior Advisor since 2023. Ruth Ch. Geßner, (LL.M. Master of Laws, MCI & Frankfurt School of Finance & Management) specialises in the profitable realignment of companies in the medical technology sector. In the last 20 years, she has successfully led business units as Vice President at Danaher / Dental and other leading listed companies. She was also responsible for the turnaround and successful exit as Managing Director at SHS portfolio company puracon GmbH.
Georg Paul Helg
SHS Senior Advisor since 2023. Since graduating from the European Business School, Georg Helg has spent more than 20 years in management positions in corporate and mergers & acquisitions consulting for Deutsche Bank and ABN AMRO. From 2011 to 2021, he was responsible for identifying investment opportunities in Germany, BeNeLux and Scandinavia for the Swiss Capvis AG as Managing Director Germany. In this role, Georg established business relationships with more than 300 M&A advisors and investment banks, as well as a large number of financial investors, family offices and entrepreneurs, managing directors and advisory/supervisory boards.
In his spare time, Georg is dedicated to the preservation and use of historic boats on Lake Zurich as a foundation board member.
Translated with www.DeepL.com/Translator (free version)
Heinz Jacqui
SHS Senior Advisor since 2020. Since receiving his degree in engineering, Heinz Jacqui has held several positions in the field of medical technology in a career spanning more than 30 years. As Global Business Unit President of Dräger Medical, he oversaw the Critical Care, Architectural Systems and Neonatal Care divisions. Working from Shanghai, for four years Jacqui managed the China trade for Dräger Medical. His next steps led him to Olympus Medical, where, as Executive Vice President, he was responsible for the global laparoscopy business. Following this position, Jacqui was named President & CEO at Maquet/ Getinge, where he oversaw the global medicine business.
Dr. Bernhard Schirmers
Dr Bernhard Schirmers, who holds a doctorate in law, founded SHS in 1993 together with Reinhilde Spatscheck and Klaus-Willi Henkes. On 31 December 2021, he relinquished his position as Managing Director of SHS Beteiligungsmanagement and is now still active as a senior advisor for SHS and in a number of mandates.
In almost 30 years, Bernhard Schirmers has developed SHS into what it is today: Germany's first specialist investor in innovative healthcare companies. During this time, SHS has invested in many companies that have shaped their market, become market leaders or have been acquired by such due to their groundbreaking products. Last but not least, these products have helped many patients worldwide to receive better treatment.
Bernhard Schirmers began his professional career at the Haftpflichtverband der Deutschen Industrie (HDI, now Talanx) in Hanover as an assistant to the board of directors, later heading the board office there. He then worked for several years as a management consultant at McKinsey & Co. in Düsseldorf.
Christian Pangratz
SHS Senior Advisor since 2023. Mr. Pangratz has a proven track record of more than 25 years in the life sciences industry. He started his career in marketing and sales at Bayer Pharmaceuticals and Pfizer in Europe before expanding his expertise in the biotech and specialty pharmaceuticals sector at companies in the US, Asia and Europe, such as Nektar Therapeutics, Activaero, SkyePharma, Vectura, Secarna Pharmaceuticals and Sterna Biologicals. Throughout his career, Christian closed M&A, co-development, and licensing transactions with a cumulative deal volume of over 4.5 billion Euros. He further raised more than 32 million Euros in venture capital for non-clinical and clinical stage development programs. Beside his leadership positions, Christian has also served as a non-executive director on the board of start-up companies and established organizations. Mr. Pangratz earned his Bachelor with an emphasis in Business Administration and a Master`s degree in International Business from Webster University in Vienna. He further completed post-graduate work at Stanford University and UC Berkeley.
Prof. Dr. med. Marc O. Schurr
SHS Senior Advisor since 2020, founder and CEO of Ovesco Endscopy AG and Managing Director of novineon Healthcare Technology Partners GmbH.
Marc O. Schurr, MD, attended the Medical School of Eberhard-Karls University Tuebingen, Germany and took his doctoral degree in the area of medical technologies. Before founding Ovesco Endoscopy he was in charge of a research programme into advanced technology of Tuebingen University and has directed a medical technology transfer center. Besides his appointment at Ovesco Endoscopy Marc Schurr is also Managing Director of novineon GmbH, an international CRO, consulting and venturing firm in the medical technology area. In the academic field he is Director of IHCI – Institute at Steinbeis University Berlin, where he is Professor of Experimental Medicine and Medical Technology.
Dr. Heinz Schwer
Dr Schwer is a partner and managing director of EVP GmbH, a consulting firm that supports pharmaceutical, biotech and medical technology companies in the areas of venture building, licensing and strategy.
Dr. Schwer was founder and managing director of several biotechnology companies in Germany, the Netherlands and Austria, all of which were successfully sold under his leadership. He developed Sloning Biotechnology in Munich into a leading manufacturer of antibody libraries and successfully completed a first clinical programme with Lanthio Pharma in Groningen. Both companies were acquired by MorphoSys AG. In Austria, he led the immuno-oncology company ViraTherapeutics as CEO until its acquisition by Boehringer Ingelheim. In addition to managing small and medium-sized biotech companies, he also worked for many years at MorphoSys AG in corporate development, corporate venture and M&A.
Dr Schwer was a post-doctoral fellow at Harvard Medical School in Boston for several years. He studied chemistry at the University of Regensburg and wrote his diploma and doctoral thesis in the field of arteriosclerosis at the university hospital. In addition to his scientific studies, he also completed a Master's programme at Henley College in England, graduating with a Master of Business Administration.
Prof. Dr. med. Adrien Daigeler
Healthcare Expert at SHS since 2021. Adrien Daigeler has been Director of the Clinic for Hand, Plastic, Reconstructive and Burn Surgery at the BG Klinik Tübingen and Chair of the subject at the Eberhard Karls University of Tübingen since 2017.
He completed his postgraduate training at the university hospitals in Magdeburg and Bochum and habilitated in the field of soft tissue sarcoma therapy. He worked as a managing and senior consultant at the BG clinics in Ludwigshafen and Tübingen.
His research focuses on soft tissue sarcomas, functional reconstruction and tissue replacement.
Prof. Dr. Alireza Gharabaghi
Heathcare expert at SHS since 2021. Prof. Dr. Alireza Gharabaghi is Medical Director of the Institute for Neuromodulation and Neurotechnology at the University Hospital Tübingen.
After studying medicine, completing an internship and a research stay at the Hannover Medical School (MHH) and Brigham and Women's Hospital (Harvard Medical School) in Boston, he received his doctorate summa cum laude in 2001 in the field of neuroregeneration. Further training in neurosurgery in Hanover and Tübingen was followed by habilitation in the field of neurofunctional localisation and preservation (2007) and leadership of the DFG research group Neuroprosthetics (2009) at the Centre for Integrative Neuroscience (CIN) excellence cluster. In 2012, Prof. Gharabaghi was appointed to chairs in the field of functional and stereotactic neurosurgery at the Albert Ludwig University of Freiburg and the Eberhard Karls University of Tübingen. He accepted the appointment in Tübingen and is committed to individualised patient care for neurodegenerative diseases (e.g. Parkinson's, dystonia, tremor), epilepsy, chronic pain and paralysis after strokes and accidents. His clinical and scientific focus is on invasive and non-invasive neuromodulation for deep and cortical brain stimulation, smart implants and electroceuticals for personalised therapies, innovative stereotaxy and surgical technologies for high-precision treatment, adaptive human-technology interfaces and neurorobotics for function-restoring neurorehabilitation.
Prof. Gharabaghi has been awarded the Theodor Fontane Prize of the Studienstiftung and the Stifterverband für die Deutsche Wissenschaft, the Bioscience Medical Technology Prize of the Klee Foundation, the European Skull Base Society Award, the Hans Joachim Denecke Prize of the German Society for Skull Base Surgery and the Traugott Riechert Prize for Functional Neurosurgery of the German Society for Neurosurgery.
Prof. Dr. Christian Hamm
Healthcare Expert of SHS since 2012, Director of the Medical Clinic I (Cardiology and Angiology) of the University Hospital Gießen and Marburg.
In addition, Medical Director and Managing Director of the Kerckhoff Clinic, Heart and Thorax Centre Bad Nauheim. Medical studies at the University of Hamburg. Afterwards research stay at the University of Cape Town (South Africa) and a position in the Department of Cardiology at the University Hospital Eppendorf in Hamburg. Habilitation in the subject "Internal Medicine". University professorship at the University Hospital Eppendorf as well as at the Justus-Liebig-University Gießen.
He was also a member of the board of the European Society of Cardiology (ESC). He is also President of the German Society of Cardiology - Heart and Circulation Research. (DGK).
Prof. Dr. Dr. h.c. Hans Henkes
Healthcare Expert to SHS since 2012 and Medical Director of the Clinic for Neuroradiology at Katharinenhospital Stuttgart.
After studying human medicine and general radiology training in Berlin, further training in diagnostic neuroradiology followed at the University Hospital Homburg/Saar. Afterwards he worked first as an assistant doctor, then as a senior physician and then as a senior consultant in the Department of Radiology and Neuroradiology at the Alfried Krupp Hospital in Essen. In addition, he headed the Department of Neuroradiology at the Robert Janker Clinic in Bonn.
Prof. Dr. med. Bernhard Krämer
Healthcare Expert at SHS since 2021. Bernhard Krämer is Deputy Medical Director of the University Women's Hospital Tübingen and Head of the certified Endometriosis Centre.
He habilitated on experimental surgical topics with a focus on peritoneal adhesions. In addition to clinical surgical activities in the entire spectrum of gynaecology, his scientific focus is on minimally invasive interventions and innovative surgical procedures.
Dr. Michael Lichtenberg
Dr Michael Lichtenberg is head physician of the Clinic for Conservative and Interventional Angiology at Klinikum Hochsauerland. He also heads the Vascular Study Centre of the Clinic for Angiology, one of the largest vascular medicine study centres in Germany. His clinical and scientific focus as an interventional angiologist is on minimally invasive therapy of peripheral arterial occlusive disease and pelvic vein thrombosis.
He has been a board member of the German Society of Angiology since 2013. From 2016-2019 he was the Society's Executive Director, and in 2020 and 2021 he led the Society as President. In recent years, he has published more than 100 scientific articles on vascular medicine topics in journals and scientific books.
Prof. Dr. med. Hubert Löwenheim
Healthcare Expert at SHS since 2021. Prof. Dr. med. Hubert Löwenheim, Full Professor of Otorhinolaryngology. Director of the Department of Otorhinolaryngology - Head and Neck Surgery, Tübingen. Head of the research group "Regenerative Medicine" at the Hearing Research Centre Tübingen.
Hubert Löwenheim studied human medicine at the University of Frankfurt, where he received his doctorate in 1995 in the field of hearing research. He spent his practical year in ENT medicine at the Massachusetts Eye and Ear Infirmary of Harvard University (Boston, USA). After research stays at the University of Virgina (Carlottesville, USA) and the University of Washington (Seattle, USA), he habilitated in the field of regenerative medicine at the University of Tübingen. Löwenheim was director of the Department of Otolaryngology - Head and Neck Surgery in Oldenburg from 2014-2016 before receiving an offer from Tübingen.
His clinical focus is on the field of otology and neurootology, including the provision of hearing implants and cochlear implants, oncological head and neck surgery with microsurgical plastic reconstruction procedures and interdisciplinary skull base surgery.
Prof. Dr. med. Florian Schmidutz, M.Sc.
Healthcare Expert at SHS since 2021. Prof. Florian Schmidutz is a specialist orthopaedic and trauma surgeon and heads the endoprosthetics section at BG Klinik Tübingen.
He studied medicine at the University of Heidelberg, Stockholm and Houston and also completed a Master of Science in Healthcare Management at the University of Mannheim/Heidelberg.
This was followed by further training at the University of Munich (LMU) and a research stay at the AO Institute Davos. His habilitation was in the field of bone-saving endoprosthetics. He was also appointed as an associate professor at the University of Munich.
Prof. Dr. Martin Spitzer
Healthcare Expert at SHS since 2021.Prof. Dr. med. Martin Spitzer has been Full Professor of Ophthalmology and Director of the University Eye Hospital Hamburg since 2016.
Prof. Dr. med. Martin Spitzer first studied medicine at the University of Regensburg, later switching to the Technical University of Munich, where he graduated magna cum laude. His specialist training took place from 2003 to 2008 at the University Eye Clinic in Tübingen. In 2006, he passed the general medical examination to obtain his full US medical licence. In 2008, he was awarded the specialist title for ophthalmology and also successfully passed the European specialist examination (FEBO). In 2010 he received his habilitation and in 2012 he was appointed as an associate professor.
The focus of his work is interdisciplinary transfer research with other disciplines, which includes the most diverse projects such as the development of hydrophilic vitreous substitutes, new laser procedures for use in ophthalmic surgery and reconstructive surgery after severe bulbar trauma. Martin Spitzer is the recipient of the Leonhard Klein Prize, which he received in 2015 for his work on vitreous body replacement.
Prof. Arnulf Stenzl
Healthcare Expert at SHS since 2021. Professor Arnulf Stenzl is Director of the Clinic and Polyclinic for Urology at the Medical Faculty of the University of Tübingen.
Professor Stenzl is author and co-author of more than 700 publications and scientific papers in peer reviewed journals, is a member of several public and privately initiated steering committees and advisory boards on a variety of urological topics. Since 2012, he has been Chair of the Scientific Congress Bureau of the European Association of Urology and is now Adjunct Secretary Science in the EAU. He is also a board member of the European Cancer Organization. He is also a member of various national and international urological associations andEditorial Board of several journals.
His main research interests are bladder and prostate cancer and reconstructive urology. He has been awarded the Jackson Hole Award of Excellence, USA. He is also an investigator of numerous clinical trials and has organised several national and international symposia on uro-oncology, - especially prostate and bladder cancer - and other urological topics. In May 2017, he was awarded the title "DOCTOR HONORIS CAUSA" for his worldwide recognition and contribution to the development in the field of urology.
Prof. Dr. med. Georg Trummer
Healthcare expert at SHS since 2022. Prof. Dr. Georg Trummer is a specialist in cardiac surgery and has additional training in special intensive care medicine and emergency medicine.
He studied at the universities of Innsbruck, Vienna and Heidelberg/Mannheim and completed the 6-month seminar "Effective Managing and Performing" at the Malik Management Zentrum St. Gallen AG. From 2003 to 2005 he was a Research Fellow at the University of California in Los Angeles (UCLA) in the laboratory of Prof. Buckberg. Since 2008, he has been senior physician and division head for cardiac and vascular surgery intensive care medicine and patient management at the University Heart Centre at Freiburg University Hospital. His work focuses on intensive care medicine and patient management, clinical process optimisation and the field of extracorporeal circulation during resuscitation.
Prof. Trummer chairs the Commission for Intensive Care Medicine of the DGHTG and is a member of the Haemodynamics Section of the DIVI as well as a representative of the Department of Surgery in the DIVI FB. He is also a founding member of Resuscitec GmbH, where he served as CMO from 2012 to 2022. He was appointed associate professor at the University of Freiburg in 2020.